Droplet Microactuator for PCR and Sequencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current PCR-based DNA amplification methods are labor-intensive, costly, and prone to cross-contamination, while nucleic acid sequencing is expensive and limited in throughput, and immunoassays require significant sample volumes and skilled technicians, making them impractical for point-of-sample collection testing.

Innovation Solution

A droplet microactuator system that uses electrodes and electromagnets to manipulate and process droplets for nucleic acid amplification, sequencing, and immunoassays, enabling miniaturization, automation, and efficient use of reagents, allowing for multiple tests on a single chip with reduced operator dependence.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If PCR-based DNA amplification methods are used, then nucleic acid detection can be performed, but the process becomes labor-intensive and prone to cross-contamination

Engineering Contradiction:
Improvecross-contamination resistanceVSAvoidlabor intensity
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The system divides the nucleic acid detection process into multiple isolated droplets, each containing separate PCR reactions. This segmentation prevents cross-contamination between samples while automating the workflow through droplet manipulation, resolving the contradiction between reliability and ease of operation

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Droplets serve as intermediaries that encapsulate individual PCR reactions and can be manipulated through microfluidic channels. This intermediary approach enables automated processing of multiple samples in parallel, reducing labor intensity while maintaining isolation to prevent cross-contamination

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If nucleic acid sequencing is performed using conventional methods, then sequencing can be achieved, but the cost is high and throughput is limited

Engineering Contradiction:
Improvesequencing throughputVSAvoidcost
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The sequencing process is segmented into multiple droplets, each containing individual DNA templates. This enables parallel processing of numerous samples simultaneously, dramatically increasing throughput while using minimal reagent volumes to reduce costs

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system transitions from conventional single-sample sequential processing to multi-dimensional parallel processing by distributing samples across multiple droplets in three-dimensional space, enabling high-throughput sequencing at reduced cost

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Ease of operation

If immunoassays are performed using conventional analyzers, then sensitive detection can be achieved, but significant sample volumes and skilled technicians are required

Engineering Contradiction:
Improveoperator dependenceVSAvoidsample volume
Core Design Contradiction:
Ease of operationVSQuantity of substance

Solution Approach 1:

The droplet-based immunoassay system is designed to perform operations automatically through programmed droplet manipulation. The system serves itself by automating sample handling, mixing, and detection processes, eliminating the need for skilled technicians while requiring only minimal sample volumes

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The immunoassay is divided into discrete droplet operations that can be automated. Each droplet contains specific reagents and samples, enabling self-contained reactions that reduce operator intervention and minimize sample volume requirements

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enables rapid, cost-effective, and sensitive nucleic acid detection and sequencing, and efficient immunoassay performance on small sample volumes, facilitating point-of-sample collection testing and reducing the need for large laboratory facilities.

Implementation Method 1

a first substrate comprising electrodes configured for conducting droplet operations on a surface of the substrate

Methodology Applied
Scientific EffectElectrostatic force: Electrostatics

Implementation Method 2

an electromagnet in sufficient proximity to a droplet to force retention of substantially all of the beads in one droplet

Methodology Applied
Scientific EffectMagnetic force: Magnetism

Data Source

PatentUS8980198B2Filler fluids for droplet operations
Publication Date: 2015.03.17 ADVANCED LIQUID LOGIC INC
  • US8980198B2 patent drawing
  • US8980198B2 patent drawing
  • US8980198B2 patent drawing

AI summary

The present invention relates to filler fluids for droplet operations. According to one embodiment of this aspect, a droplet microactuator is provided and includes: (a) a first substrate comprising electrodes configured for conducting droplet operations on a surface of the substrate; (b) a second substrate spaced from the surface of the substrate by a distance sufficient to define an interior volume between the first substrate and second substrate, wherein the distance is sufficient to contain a droplet disposed in the space on the first substrate; and (c) a droplet arranged in the interior volume and arranged with respect to the electrodes in a manner which permits droplet operations to be effected on the droplet using the electrodes.